期刊
CLIMACTERIC
卷 11, 期 4, 页码 273-279出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/13697130802227724
关键词
women's health; menopause; hormone replacement therapy; estrogens; progestogens; venous thromboembolism
Venous thromboembolism (VTE) is an important determinant of the benefit-to-risk profile of postmenopausal hormone replacement therapy (HRT). Women's health practitioners who prescribe HRT to their patients are often more concerned about the thromboembolic complications than the risk of breast malignancy. This is in contrast to their patients who are eligible and considering commencing hormonal treatment where breast cancer is often the primary concern. This review summarizes the data on the actual HRT-related VTE risk and factors influencing it. It also provides practical guidelines which should support the health professional in ensuring informed choice on HRT for women.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据